Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 7174858, 6 pages
https://doi.org/10.1155/2017/7174858
Research Article

Anticancer Effects of the Marine Sponge Lipastrotethya sp. Extract on Wild-Type and p53 Knockout HCT116 Cells

1College of Pharmacy, Duksung Women’s University, Seoul 01369, Republic of Korea
2Innovative Drug Center, Duksung Women’s University, Seoul 01369, Republic of Korea

Correspondence should be addressed to Joohee Jung; rk.ca.gnuskud@eehooj

Received 13 October 2016; Revised 8 December 2016; Accepted 21 December 2016; Published 3 January 2017

Academic Editor: Hilal Zaid

Copyright © 2017 Kiheon Choi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Sumii, N. Kotoku, A. Fukuda, T. Kawachi, M. Arai, and M. Kobayashi, “Structure-activity relationship and in vivo anti-tumor evaluations of dictyoceratin-A and -C, hypoxia-selective growth inhibitors from marine sponge,” Marine Drugs, vol. 13, no. 12, pp. 7419–7432, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. D. T. A. Youssef, L. A. Shaala, and K. Z. Alshali, “Bioactive hydantoin alkaloids from the Red Sea marine sponge Hemimycale arabica,” Marine Drugs, vol. 13, no. 11, pp. 6609–6619, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. S.-Y. Wu, P.-J. Sung, Y.-L. Chang, S.-L. Pan, and C.-M. Teng, “Heteronemin, a spongean sesterterpene, induces cell apoptosis and autophagy in human renal carcinoma cells,” BioMed Research International, vol. 2015, Article ID 738241, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. H.-Y. Lee, K. J. Chung, I. H. Hwang et al., “Activation of p53 with ilimaquinone and ethylsmenoquinone, marine sponge metabolites, induces apoptosis and autophagy in colon cancer cells,” Marine Drugs, vol. 13, no. 1, pp. 543–557, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. R. Alison and C. E. Sarraf, “Apoptosis: a gene-directed programme of cell death,” Journal of the Royal College of Physicians of London, vol. 26, no. 1, pp. 25–35, 1992. View at Google Scholar · View at Scopus
  6. T. G. Cotter, S. V. Lennon, J. G. Glynn, and S. J. Martin, “Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells,” Anticancer Research, vol. 10, no. 5, pp. 1153–1159, 1990. View at Google Scholar · View at Scopus
  7. E. White, “The role for autophagy in cancer,” Journal of Clinical Investigation, vol. 125, no. 1, pp. 42–46, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Y. Guo, B. Xia, and E. White, “Autophagy-Mediated tumor Promotion,” Cell, vol. 155, no. 6, pp. 1216–1219, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Hjelmeland and J. Zhang, “Metabolic, autophagic, and mitophagic activities in cancer initiation and progression,” Biomedical Journal, vol. 39, no. 2, pp. 98–106, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Ratovitski, “Tumor protein (TP)-p53 members as regulators of autophagy in tumor cells upon marine drug exposure,” Marine Drugs, vol. 14, no. 8, p. 154, 2016. View at Publisher · View at Google Scholar
  11. L. Zhang, D. Xie, X. Chen et al., “p53 Mediates colistin-induced autophagy and apoptosis in PC-12 cells,” Antimicrobial Agents and Chemotherapy, vol. 60, no. 9, pp. 5294–5301, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. K. M. Livesey, R. Kang, P. Vernon et al., “p53/HMGB1 complexes regulate autophagy and apoptosis,” Cancer Research, vol. 72, no. 8, pp. 1996–2005, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J.-W. Lee, H.-S. Lee, J. Shin et al., “Suvanine analogs from a Coscinoderma sp. marine sponge and their cytotoxicities against human cancer cell lines,” Archives of Pharmacal Research, vol. 38, no. 6, pp. 1005–1010, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. H. K. Lim, W. Bae, H.-S. Lee, and J. Jung, “Anticancer activity of marine sponge Hyrtios sp. extract in human colorectal carcinoma RKO cells with different p53 status,” BioMed Research International, vol. 2014, Article ID 413575, 5 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. L. Gartel and A. L. Tyner, “The role of the cyclin-dependent kinase inhibitor p21 in apoptosis,” Molecular Cancer Therapeutics, vol. 1, no. 8, pp. 639–649, 2002. View at Google Scholar · View at Scopus
  16. H. Ko, J. M. Kim, S.-J. Kim, S. H. Shim, C. H. Ha, and H. I. Chang, “Induction of apoptosis by genipin inhibits cell proliferation in AGS human gastric cancer cells via Egr1/p21 signaling pathway,” Bioorganic and Medicinal Chemistry Letters, vol. 25, no. 19, pp. 4191–4196, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Kim and J. Shohet, “Targeted molecular therapy for neuroblastoma: the ARF/MDM2/p53 axis,” Journal of the National Cancer Institute, vol. 101, no. 22, pp. 1527–1529, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. P.-J. Hamard and J. Manfredi, “Mdm2's dilemma: to degrade or to translate p53?” Cancer Cell, vol. 21, no. 1, pp. 3–5, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Maglic, S. Zhu, E. A. Fry et al., “Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer,” Oncogene, vol. 32, no. 35, pp. 4120–4129, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. E. K. Markert, H. Mizuno, A. Vazquez, and A. J. Levine, “Molecular classification of prostate cancer using curated expression signatures,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 52, pp. 21276–21281, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J.-H. Lee, J.-E. Jeon, Y.-J. Lee et al., “Nortriterpene glycosides of the sarasinoside class from the sponge Lipastrotethya sp,” Journal of Natural Products, vol. 75, no. 7, pp. 1365–1372, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. J.-H. Lee, K. H. Jang, Y.-J. Lee et al., “Triterpene galactosides of the pouoside class and corresponding aglycones from the sponge Lipastrotethya sp,” Journal of Natural Products, vol. 74, no. 12, pp. 2563–2570, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-X. Li, S. W. A. Himaya, and S.-K. Kim, “Triterpenoids of marine origin as anti-cancer agents,” Molecules, vol. 18, no. 7, pp. 7886–7909, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. R. Patlolla and C. V. Rao, “Triterpenoids for cancer prevention and treatment: current status and future prospects,” Current Pharmaceutical Biotechnology, vol. 13, no. 1, pp. 147–155, 2012. View at Publisher · View at Google Scholar · View at Scopus